Close Menu

NEW YORK (GenomeWeb) – Gene editing technology company Inscripta said today that it plans to acquire Solana Biosciences, a life sciences company founded in 2017 by former Illumina employees.

The acquisition will help accelerate the commercialization of Inscripta's gene editing tools by assembling a life science product development and manufacturing pipeline for precision gene editing, the firm said. Terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.